ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,498Medicare Part D Prescriptions Filled, Including Refills

Rank: 125 out of 1677

$1.11M Total Retail Price of All Prescriptions

Rank: 56 out of 1677

607 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 607 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 607 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 14,491 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
AMLODIPINE BESYLATE 742 687 1 2
LEVOTHYROXINE SODIUM 637 617 2 5
LISINOPRIL 572 536 3 3
LOSARTAN POTASSIUM 509 495 4 25
ATORVASTATIN CALCIUM 482 448 5 13
WARFARIN SODIUM 477 474 6 24
SIMVASTATIN 471 456 7 1
FENOFIBRATE 429 367 8 48
METOPROLOL TARTRATE 417 407 9 12
PRAVASTATIN SODIUM 367 309 10 10
OMEPRAZOLE 319 293 11 6
FUROSEMIDE 313 312 12 8
CRESTOR 303 292 13 28
ZETIA 287 270 14 75
JANUVIA 264 250 15 70
ATENOLOL 238 231 16 21
METFORMIN HCL 231 212 17 7
FLUTICASONE PROPIONATE 205 193 18 29
CITALOPRAM HBR 199 192 19 22
INDAPAMIDE 198 184 20 222
FLUOXETINE HCL 184 163 21 49
ACTOS 175 169 22 104
GLIPIZIDE 170 162 23 56
TERAZOSIN HCL 169 161 24 138
NAMENDA 162 162 25 39
METOPROLOL SUCCINATE 150 135 26 23
CARBIDOPA-LEVODOPA 148 130 27 131
SYNTHROID 147 124 28 55
PREDNISONE 135 133 29 40
CLOPIDOGREL 133 133 30 32
SERTRALINE HCL 131 118 31 26
QUINAPRIL HCL 131 126 31 163
DONEPEZIL HCL 122 122 33 30
HYDROCODONE-ACETAMINOPHEN 119 116 S3 34 4
POTASSIUM CHLORIDE 117 116 35 14
ALLOPURINOL 117 116 35 31
PIOGLITAZONE HCL 111 99 R 37 252
GABAPENTIN 111 97 37 11
NIASPAN 103 99 39 128
CARVEDILOL 96 91 40 20
PLAVIX 96 88 40 47
RAMIPRIL 95 88 42 118
NEXIUM 86 73 43 19
AMOX TR-POTASSIUM CLAVULANATE 83 81 44 126
TAMSULOSIN HCL 82 82 45 34
MELOXICAM 82 76 45 27
ADVAIR DISKUS 80 80 47 54
LANTUS 79 78 48 44
ZOLPIDEM TARTRATE 79 79 48 15
DOXYCYCLINE HYCLATE 79 73 48 96
DIGOXIN 70 70 51 71
NOVOLIN R 69 68 52 133
FINASTERIDE 67 60 53 130
BUPROPION HCL SR 65 62 54 188
EXELON 63 63 55 119
VYTORIN 62 55 56 192
CYCLOBENZAPRINE HCL 61 58 R 57 52
RIVASTIGMINE 60 60 58 271
CYMBALTA 60 49 58 58
RANITIDINE HCL 59 59 60 18
TRAZODONE HCL 58 58 61 37
HYDROCHLOROTHIAZIDE 55 54 62 9
ALENDRONATE SODIUM 55 50 62 43
SINGULAIR 53 36 64 97
RISPERIDONE 52 51 65 60
METFORMIN HCL ER 50 48 66 51
HUMALOG 50 50 66 224
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 17, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.